Autoantibodies to T-cell receptor beta chains in human heart transplantation: epitope and spectrotype analyses and kinetics of response
- PMID: 9165272
Autoantibodies to T-cell receptor beta chains in human heart transplantation: epitope and spectrotype analyses and kinetics of response
Abstract
Autoantibodies against T-cell receptors have been found in two alloimmunization situations in humans: renal transplantation and pregnancy. We carried out longitudinal studies of human heart transplant recipients monitoring their autoantibody production to a recombinant single chain T-cell receptor V alpha/V beta construct, a set of nested, overlapping peptides duplicating the complete covalent structure of an individual T-cell receptor beta chain and a set of peptides duplicating the first complementarity determining segments of 24 distinct human V beta gene products in order to define the time course, epitope specificity and recognition heterogeneity of the response. Autoantibodies against intact and peptide-defined V beta and C beta determinants were generated following human heart allotransplantation. The responses generally show an increase following transplantation that subsequently decreases with time, a result which is consistent with a single immunization. However, some patients showed elevated responses as long as 12 months following the transplant. Autoantibody anti-CDR1 spectrotype analyses detected individual differences among patients, but 5 of 8 patients characterized in detail showed elevated IgG binding to CDR1 peptide epitopes of V beta 6.1, 21.1 and 22.1 gene products. Autoantibodies to CDR1 epitopes of V beta 7.1 and 8.1 were high pretransplant and remained high, although the relative increases with respect to the pretransplant values were not as impressive as those for the above CDR1 epitopes and others usually present in low quantity, e.g. anti-V beta 2.1, 3.1 and 24.1. Although there was great disparity between the MHC haplotypes of donors and recipients, and individual differences among patients, the degree of restriction in the autoantibody response was surprising and suggests a common step in recognition and regulation of the response to allografts.
Similar articles
-
Human autoantibodies to a synthetic putative T cell receptor beta-chain regulatory idiotype: expression in autoimmunity and aging.Exp Clin Immunogenet. 1993;10(1):1-15. Exp Clin Immunogenet. 1993. PMID: 8398197
-
Recognition of defined epitopes by affinity-purified anti-immunoglobulin fab autoantibodies isolated from HIV-infected humans.J Mol Recognit. 1999 May-Jun;12(3):169-76. doi: 10.1002/(SICI)1099-1352(199905/06)12:3<169::AID-JMR459>3.0.CO;2-6. J Mol Recognit. 1999. PMID: 10398407
-
Binding of human IgG myeloma proteins to autologous T-cell receptor determinants.Crit Rev Immunol. 1997;17(5-6):497-506. Crit Rev Immunol. 1997. PMID: 9419436
-
T-cell receptor-derived peptides in immunoregulation and therapy of retrovirally induced immunosuppression.Crit Rev Immunol. 2001;21(1-3):57-74. Crit Rev Immunol. 2001. PMID: 11642614 Review.
-
Structural, antigenic and evolutionary analyses of immunoglobulins and T cell receptors.J Mol Recognit. 2002 Sep-Oct;15(5):260-71. doi: 10.1002/jmr.586. J Mol Recognit. 2002. PMID: 12447902 Review.
Cited by
-
Production and characterization of monoclonal IgM autoantibodies specific for the T-cell receptor.J Protein Chem. 2000 Jan;19(1):9-21. doi: 10.1023/a:1007086608036. J Protein Chem. 2000. PMID: 10882168
-
Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells.Immunology. 2002 Apr;105(4):419-29. doi: 10.1046/j.1365-2567.2002.01389.x. Immunology. 2002. PMID: 11985662 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials